Pricing Log in Create free account

ENDRA Life Sciences Inc. (NDRA) vs Precipio, Inc. (PRPO)

ENDRA Life Sciences Inc. and Precipio, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $33.3M against $7.5M — 4.4× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −4.47%) and the lower return on invested capital (−539.9% vs −7.63%). Across the 16 metrics below, Precipio, Inc. leads on 11 and ENDRA Life Sciences Inc. on 5.

Valuation

Metric NDRA PRPO Diagnostics & Research median
P/E n/m n/m 34.52
P/S 17.21 1.25 4.24
P/B 0.98 2.30 3.42
Price to free cash flow n/m 43.09 33.51
EV/EBITDA n/m 107.75 23.44
EV/Sales 1.88 1.17 5.18
Earnings yield (127.31%) (3.36%) (1.50%)
Free cash flow yield (127.37%) 2.32% 0.00%

Profitability

Metric NDRA PRPO Diagnostics & Research median
Gross margin 0.00% 44.11% 48.32%
Operating margin 0.00% (5.68%) (5.68%)
Net margin 0.00% (4.47%) (4.10%)
Free cash flow margin 0.00% 2.90% 0.00%
Return on equity (152.04%) (8.98%) 0.00%
Return on assets (110.08%) (6.05%) (6.05%)
Return on invested capital (539.89%) (7.63%) 0.00%

Growth

Metric NDRA PRPO Diagnostics & Research median
Revenue growth (TTM) — 28.04% 8.99%
EPS growth (last fiscal year) 84.32% 92.15% 20.36%
Revenue growth, 5-year CAGR — 31.60% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA PRPO Diagnostics & Research median
Debt to equity 0.00 0.07 0.01
Current ratio 7.10 1.77 2.27
Net debt to EBITDA 0.14 (3.30) 0.68

Dividend

Metric NDRA PRPO Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric NDRA PRPO Diagnostics & Research median
Market cap 7.51m 33.28m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack